Hormone replacement therapy has been debated for more than two decades. Many women still remember headlines connecting menopause hormones with breast cancer, heart disease, and other serious conditions. The medical discussion has changed as researchers have learned more about age, timing, hormone type, route of administration, and individual risk.
A major update arrived in February 2026. FDA approved labeling changes for six menopausal hormone therapy products and removed statements about cardiovascular disease, breast cancer, and probable dementia from their boxed warnings. The change does not mean HRT is risk-free. It means hormone therapy decisions should reflect current evidence and each woman’s medical history.
What Is Hormone Replacement Therapy for Menopause?
Hormone replacement therapy, also called menopausal hormone therapy, uses estrogen and sometimes a progestogen to treat symptoms related to menopause. Systemic estrogen may be delivered through pills, patches, gels, or sprays. Local vaginal estrogen is used mainly for vaginal and urinary symptoms.
Women with a uterus usually need a progestogen with systemic estrogen because estrogen alone can increase the risk of endometrial cancer. Women who have had a hysterectomy may be able to use estrogen without progestogen.
What Changed With HRT in 2026?
On February 12, 2026, FDA announced approved labeling changes for six menopausal hormone therapy products. Statements about cardiovascular disease, breast cancer, and probable dementia were removed from the boxed warning for those products.
This update should not be interpreted as “HRT has no risks.” Hormone type, dose, route, age, medical history, time since menopause, and whether progesterone is needed still affect the risk and benefit discussion.

Why Did HRT Become So Controversial?
Much of the fear around hormone therapy followed early results from the Women’s Health Initiative in the early 2000s. The findings were often interpreted broadly, even though later analysis showed that age, timing, hormone formulation, and patient characteristics matter.
Current menopause care therefore focuses less on labeling HRT as universally good or bad. The better approach is deciding whether its likely benefits outweigh the risks for a specific person.
What Symptoms Can HRT Help?
Hormone therapy is mainly used for bothersome menopause symptoms such as:
- Hot flashes
- Night sweats
- Sleep problems linked to vasomotor symptoms
- Vaginal dryness
- Pain during sex
- Genitourinary symptoms
- Menopause-related bone loss
ACOG states that systemic estrogen is the most effective treatment for hot flashes and night sweats. Systemic estrogen also protects against bone loss that occurs early in menopause.
What Are the Main Benefits of HRT?
For the right patient, hormone therapy can greatly reduce hot flashes and night sweats. Better symptom control can also improve sleep and daily quality of life when those symptoms are disruptive.
Systemic estrogen also helps protect bone density. Local vaginal estrogen can be useful when the main concern is vaginal dryness, discomfort, or other genitourinary symptoms rather than whole-body symptoms.
Who May Be a Good Candidate for Menopause HRT?
The Menopause Society says the benefit-risk balance is generally favorable for many healthy women who start hormone therapy before age 60 or within about 10 years of menopause onset, particularly when they have bothersome symptoms. That is not a universal rule, but timing is an important part of the discussion.
A provider should also consider symptoms, personal history, family history, medications, cardiovascular risk, cancer history, clotting history, and whether the patient still has a uterus.
Who May Not Be a Good Candidate?
Systemic hormone therapy may not be appropriate for some women with a history of breast or endometrial cancer, stroke, heart attack, blood clots, or liver disease. Pregnancy is another reason systemic menopause hormone therapy should not be used.
Having one risk factor does not mean every menopause treatment is unavailable. Nonhormonal therapies and local treatments may still be options depending on the situation.

What Risks of HRT Still Matter?
Potential risks can include blood clots, stroke, breast cancer considerations, gallbladder problems, and endometrial cancer if systemic estrogen is used without adequate uterine protection. The size of these risks can differ depending on age, treatment duration, hormone combination, route, and individual health.
This is why the 2026 labeling change should be explained carefully. Removing certain boxed-warning statements does not remove the need for informed medical decision making.
HRT Patch vs Pill vs Gel
| Type | How It Is Used | Common Role |
|---|---|---|
| Oral estrogen | Taken by mouth | Systemic symptoms |
| Estrogen patch | Applied to skin | Systemic symptoms |
| Estrogen gel or spray | Applied to skin | Systemic symptoms |
| Vaginal estrogen | Cream, tablet, or ring | Vaginal and urinary symptoms |
Different delivery methods may have different risk profiles and convenience factors. A provider can help determine which route makes sense based on symptoms and medical history.
Do You Need Progesterone With Estrogen?
Women who still have a uterus generally need a progestogen when using systemic estrogen. This protects the uterine lining from the effects of estrogen alone.
Women who have had their uterus removed may not need the same protection. Treatment should still be individualized.
What Does “Bioidentical HRT” Mean?
Bioidentical hormones have a chemical structure that is identical to hormones produced by the human body. Some FDA-approved hormone products are bioidentical. The term should not automatically be interpreted as meaning compounded, natural, safer, or better.
ACOG recommends FDA-approved hormone therapy over compounded hormone therapy when an approved option can meet the patient’s needs.
Are Compounded Bioidentical Hormones Safer?
There is not good evidence that compounded bioidentical hormones are automatically safer or more effective than FDA-approved menopause hormone products. Compounded medications may be appropriate in certain situations, but they do not undergo the same FDA premarket review.
Patients should ask whether their medication is FDA approved or compounded and why that specific formulation is being recommended.
What About Hormone Pellets?
Hormone pellets are inserted under the skin and release hormones over time. Some patients like the convenience because dosing does not require a daily pill, patch, or cream. However, once a pellet is inserted, it cannot be easily removed if the dose produces unwanted effects.
901 Aesthetics currently lists topical creams and pellets among hormone options for women and uses estrogen, progesterone, or testosterone depending on individual needs.

Does HRT Prevent Heart Disease or Dementia?
Hormone therapy should not be started solely as a general anti-aging treatment or as a guaranteed way to prevent heart disease or dementia. Menopause treatment should focus on approved indications and a person’s individual risk-benefit profile.
The 2026 FDA labeling update changed specific boxed-warning language. It did not turn menopausal hormone therapy into a preventive treatment for every age-related disease.
How Long Can You Stay on HRT?
There is no single treatment duration that fits every woman. ACOG recommends reviewing the decision regularly based on current symptoms, risks, benefits, and personal preferences. Some women may use hormone therapy longer when symptoms continue.
The decision to continue should be reassessed instead of automatically stopping treatment at a specific birthday.
What If HRT Is Not Right for You?
Nonhormonal treatments can help manage menopause symptoms. Options may include certain medications for hot flashes, vaginal moisturizers, lubricants, and other symptom-specific treatments.
A treatment plan should focus on the symptoms that matter most rather than treating menopause as one single condition.
Hormone Replacement Therapy in Germantown, TN
901 Aesthetics offers hormone replacement therapy in Germantown for adults dealing with hormone-related concerns. Its current women’s treatment options include topical hormones and hormone pellets, with treatment plans based on consultation and patient-specific factors.
For women dealing specifically with menopause symptoms, the goal should be informed treatment rather than simply raising hormone levels. Medical history, symptom severity, expected benefits, and possible risks should all guide the decision.
Final Takeaway
Hormone replacement therapy remains one of the most effective treatments for significant menopause symptoms. The major change in 2026 was an update to FDA boxed-warning language for several products, not a declaration that HRT has zero risk.
Women considering HRT in Germantown should discuss symptoms, medical history, treatment route, hormone type, and personal risk factors. The best plan is one based on current evidence rather than old fear or new hype.



